Pathophysiology of meningiomas

Brian Ragel, Randy L. Jensen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This article provides a brief description of the current knowledge of meningioma tumorigenesis and biology. Meningioma grade, subtyping, histology, and MIB-1 labeling index are discussed in relationship to tumor behavior and recurrence prediction. Chromosomal abnormalities associated with meningioma development are discussed with an emphasis on chromosome 22 and the neurofibromatosis type 2 gene. The current knowledge of prognostic features of 1p deletions is outlined. The role of sex hormones in meningioma growth and development is also discussed and summarized. To date, treatment regimens based on inhibiting hormonally mediated meningioma growth have been disappointing. Research concerning growth factors and peptide hormones that have been implicated in meningioma tumorigenesis is discussed. It is hoped that further understanding of the biology of meningioma development, growth, and angiogenesis will lead to new successful treatments for refractory meningiomas.

Original languageEnglish (US)
Pages (from-to)169-185
Number of pages17
JournalSeminars in Neurosurgery
Volume14
Issue number3
DOIs
StatePublished - Sep 2003
Externally publishedYes

Fingerprint

Meningioma
Growth and Development
Neurofibromatosis 2 Genes
Carcinogenesis
Neurofibromatosis 2
Chromosomes, Human, Pair 22
Peptide Hormones
Gonadal Steroid Hormones
Chromosome Aberrations
Growth Hormone
Intercellular Signaling Peptides and Proteins
Histology
Recurrence
Therapeutics
Growth
Research

Keywords

  • Histology
  • Meningioma tumorigenesis
  • Prognosis
  • Tumor grading

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pathophysiology of meningiomas. / Ragel, Brian; Jensen, Randy L.

In: Seminars in Neurosurgery, Vol. 14, No. 3, 09.2003, p. 169-185.

Research output: Contribution to journalArticle

Ragel, B & Jensen, RL 2003, 'Pathophysiology of meningiomas', Seminars in Neurosurgery, vol. 14, no. 3, pp. 169-185. https://doi.org/10.1055/s-2004-817734
Ragel, Brian ; Jensen, Randy L. / Pathophysiology of meningiomas. In: Seminars in Neurosurgery. 2003 ; Vol. 14, No. 3. pp. 169-185.
@article{c8b7f0ff58cc422cad7d5ecef2899641,
title = "Pathophysiology of meningiomas",
abstract = "This article provides a brief description of the current knowledge of meningioma tumorigenesis and biology. Meningioma grade, subtyping, histology, and MIB-1 labeling index are discussed in relationship to tumor behavior and recurrence prediction. Chromosomal abnormalities associated with meningioma development are discussed with an emphasis on chromosome 22 and the neurofibromatosis type 2 gene. The current knowledge of prognostic features of 1p deletions is outlined. The role of sex hormones in meningioma growth and development is also discussed and summarized. To date, treatment regimens based on inhibiting hormonally mediated meningioma growth have been disappointing. Research concerning growth factors and peptide hormones that have been implicated in meningioma tumorigenesis is discussed. It is hoped that further understanding of the biology of meningioma development, growth, and angiogenesis will lead to new successful treatments for refractory meningiomas.",
keywords = "Histology, Meningioma tumorigenesis, Prognosis, Tumor grading",
author = "Brian Ragel and Jensen, {Randy L.}",
year = "2003",
month = "9",
doi = "10.1055/s-2004-817734",
language = "English (US)",
volume = "14",
pages = "169--185",
journal = "Seminars in Neurosurgery",
issn = "1526-8012",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Pathophysiology of meningiomas

AU - Ragel, Brian

AU - Jensen, Randy L.

PY - 2003/9

Y1 - 2003/9

N2 - This article provides a brief description of the current knowledge of meningioma tumorigenesis and biology. Meningioma grade, subtyping, histology, and MIB-1 labeling index are discussed in relationship to tumor behavior and recurrence prediction. Chromosomal abnormalities associated with meningioma development are discussed with an emphasis on chromosome 22 and the neurofibromatosis type 2 gene. The current knowledge of prognostic features of 1p deletions is outlined. The role of sex hormones in meningioma growth and development is also discussed and summarized. To date, treatment regimens based on inhibiting hormonally mediated meningioma growth have been disappointing. Research concerning growth factors and peptide hormones that have been implicated in meningioma tumorigenesis is discussed. It is hoped that further understanding of the biology of meningioma development, growth, and angiogenesis will lead to new successful treatments for refractory meningiomas.

AB - This article provides a brief description of the current knowledge of meningioma tumorigenesis and biology. Meningioma grade, subtyping, histology, and MIB-1 labeling index are discussed in relationship to tumor behavior and recurrence prediction. Chromosomal abnormalities associated with meningioma development are discussed with an emphasis on chromosome 22 and the neurofibromatosis type 2 gene. The current knowledge of prognostic features of 1p deletions is outlined. The role of sex hormones in meningioma growth and development is also discussed and summarized. To date, treatment regimens based on inhibiting hormonally mediated meningioma growth have been disappointing. Research concerning growth factors and peptide hormones that have been implicated in meningioma tumorigenesis is discussed. It is hoped that further understanding of the biology of meningioma development, growth, and angiogenesis will lead to new successful treatments for refractory meningiomas.

KW - Histology

KW - Meningioma tumorigenesis

KW - Prognosis

KW - Tumor grading

UR - http://www.scopus.com/inward/record.url?scp=2442695421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442695421&partnerID=8YFLogxK

U2 - 10.1055/s-2004-817734

DO - 10.1055/s-2004-817734

M3 - Article

AN - SCOPUS:2442695421

VL - 14

SP - 169

EP - 185

JO - Seminars in Neurosurgery

JF - Seminars in Neurosurgery

SN - 1526-8012

IS - 3

ER -